Clinical trial
MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)
NCT06879873 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)
- Lead sponsor
- Fudan University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 1, 2025
- Completion date
- July 31, 2029
- Enrollment
- 390 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer (crc)